Maintaining a Healthy Lifestyle Decreases Risk for Peripheral Artery Disease
A prospective cohort study was conducted to determine the relationship between multiple modifiable lifestyle factors and risk for peripheral artery disease.
A prospective cohort study was conducted to determine the relationship between multiple modifiable lifestyle factors and risk for peripheral artery disease.
Researchers sought to determine the relationship between lower extremity peripheral artery disease and outcomes for acute myocardial infarction and cardiogenic shock.
Researchers assessed the safety and efficacy of paclitaxel (PTX) devices for treating peripheral artery disease involving the femoropopliteal artery.
Using 2 national cohorts 10 years apart, researchers compared the mean age of young adults, who were hospitalized for PVD with CV comorbidities and major adverse cardiac and cerebrovascular events.
Researchers sought to determine if peripheral artery disease is an independent risk factor for heart failure.
Researchers aimed to determine if remnant cholesterol was associated with increased risk for peripheral artery disease.
Researchers sought to assess whether smoking before open and endovascular revascularization for intermittent claudication increased risk for postprocedural complications.
Combining varenicline with nicotine patch, extending treatment from 12 to 24 weeks did not increase smoking cessation rates
Higher doses of statins may more effectively prevent adverse clinical outcomes in PAD.
A meta-analysis of COMPASS and VOYAGER compared low-dose rivaroxaban and aspirin vs aspirin alone across a broad spectrum of patients with PAD.